|
|
|
Nancy Pei practises exclusively in the field of pharmaceuticals. She has over a decade of experience with pharmaceutical patent and related litigation and in providing regulatory advice to clients operating in this industry.
Ms. Pei represents innovative pharmaceutical companies in litigation relating to the Patented Medicines (Notice of Compliance) Regulations and in patent infringement actions. She has represented clients before the Federal Court of Canada, the Federal Court of Appeal, the Supreme Court of Canada, the Ontario Superior Court of Justice, and in opposition proceedings before the Canadian Intellectual Property Office. She also provides advice on matters relating to patent listing, data protection, the Patented Medicine Prices Review Board, and access to information requests. Ms. Pei’s hands-on experience as a pharmacist coupled with the expertise gained through her highly focussed yet diverse practice afford her a unique position in examining broader patenting and regulatory issues of importance to innovative pharmaceutical clients.
Ms. Pei has been the editor of Rx IP Update, the firms' monthly pharmaceutical intellectual property and regulatory newsletter, since its inception in 2001.
|
|
|
Memberships
- Fellow, Intellectual Property Institute of Canada
- Member, Canadian Bar Association
Speaking engagements
- "Supreme Court of Canada PLAVIX Decision: The Aftermath," panel discussion at the Drug Patent and Legal Forum, Toronto, May 2009
- "Selecting the Right Expert," Advocacy Before the Federal Court in Intellectual Property Matters — Expert Witnesses, Canadian Bar Association, Ottawa, May 2008
- "The AstraZeneca Decision of the Supreme Court of Canada — Downstream Effects," Drug Patents and Legal Forum, Insight Information, Toronto, February 2008
- "Patent Time Lines: Maximizing Possibilities from Both Perspectives" (co-presenter: Angela Furlanetto, Dimock Stratton LLP), 6th Annual Forum on Pharma Patents, Canadian Institute, Toronto, October 2007
- "Changes to Patented Medicines (NOC) Regulations — Industry Perspective" (co-presenter: Gunars A. Gaikis), From Product Monograph to Promotion and Other Emerging Initiatives, Canadian Association of Professional Regulatory Affairs, Toronto, November 2007
- "Maintaining Profitability while Minimizing the Impact of Patent Expiry and Generic Entry," Drug Pricing & Reimbursement in Canada Conference, Canadian Institute, Toronto, June 2007
- "Developing and Managing Your Patent Portfolio — Maximizing Patent Life Cycles and Minimizing the Impact of Patent Expiry and Innovation Uncertainty" (co-presenter: Yoon Kang), 5th Annual Forum on Pharma Patents, Canadian Institute, Toronto, October 2006
|
|
